US approves updated Pfizer, Moderna shots targeting Omicron / Photo: © AFP/File
-
Man charged over suspected anti-Muslim attacks in Edinburgh
-
Room heroics earn Curacao World Cup point against Ecuador
-
Britain's King Charles to reveal personal tax bill: reports
-
New mindset, prior win give Clark confidence at US Open
-
Fly-half Love ready for All Blacks start after Super Rugby heroics
-
Scheffler eager to seize the moment as career slam beckons
-
Saudis seek to repeat Argentina World Cup 'miracle' against Spain
-
Clark leads by six at US Open as Scheffler charges
-
Nagelsmann says Germany has higher ambitions than advancing to knockout stage
-
Los Angeles under state of emergency due to warehouse fire
-
US and Iran set for new talks after delay and deadly strikes
-
'Fired up' Spain ready to hit back, says De la Fuente
-
Germany into World Cup last 32 after late comeback, Dutch thrash Sweden
-
Germany come from behind to beat Ivory Coast and reach World Cup last 32
-
Albanian protests against Trump-linked resort swell
-
Clark clings to US Open lead as Scheffler charges
-
Burn dons cowboy boots as England unwind at World Cup
-
Miotti kicks Montpellier past Stade Francais into Top 14 final
-
France's Saliba says playing through the pain at World Cup
-
Iran says Hormuz closed as US-Iran deal falters over Lebanon
-
Counter-terror cops probe suspected anti-Muslim 'attacks' in Edinburgh
-
Bagnaia scorches to Czech MotoGP sprint victory, Bezzecchi suspended
-
Clark begins with bogey as McIlroy charges at US Open
-
Bolivia declares state of emergency, deploys military to quell protests
-
Specter of military escalation hangs over Colombia vote
-
Heavy metal: French town hosts medieval combat cage fights
-
Jamieson strikes as New Zealand eye series-levelling win despite Root heroics
-
Dutch swat Sweden as Germany, Ivory Coast eye World Cup knockout rounds
-
Netherlands thump Sweden in Houston to get World Cup liftoff
-
Scheffler opens with bogeys while McIlroy pars at windy US Open
-
Jamieson strikes as New Zealand eye series-levelling win against England
-
Brazil turn corner but tougher World Cup tests await
-
Ronaldinho coming out of retirement to join Italian 3rd division side
-
Cerundolo sees off Nakashima to set up Queen's final with Paul
-
Real Madrid say no contact with Bayern's Olise
-
Fritz takes down Zverev again to reach Halle final
-
Heartbreak for Japanese ace Satono Reve as Almeraq wins Royal Ascot thriller
-
Hendy quick-fire double sweeps Northampton to Prem title
-
Injured Doris out of Ireland's Nations Championship squad
-
'Not ridiculous': US dreams of World Cup glory after big wins
-
Meloni hits back as Trump escalates G7 photo spat
-
Kolbe star goal kicker as Springboks put 80 past Barbarians
-
Pogacar pips Van der Poel to Swiss Tour TT win
-
Bolivia declares state of emergency and begins removing protester roadblocks
-
Ukraine's Zelensky, top officials return Polish awards in WWII row
-
Cerundolo sees off Nakashima to reach Queen's final
-
Spanish judge bans PM's wife from leaving country
-
Jamieson double rocks England at start of record run-chase
-
Pegula powers past Sabalenka to reach Berlin final
-
Funeral for art giant David Hockney already taken place: publicist
US approves updated Pfizer, Moderna shots targeting Omicron
US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, with the goal of jump-starting a new booster campaign.
The two updated booster shots aimed at providing "better protection against Covid-19 caused by the Omicron variant" are approved for people age 12 and above for the Pfizer shot and 18 and older for Moderna, the Food and Drug Administration (FDA) said in a statement.
This new generation of anti-Covid vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing the most cases in the United States and which the FDA predicts will circulate in the coming months.
Earlier this summer the US health department announced it had purchased 105 million doses from Pfizer and 66 million from Moderna for use over the fall and winter.
The vaccines have yet to be recommended by the Centers for Disease Control and Prevention, the nation's health protection agency. But an independent panel of experts is scheduled to be convened by the CDC on Thursday to discuss the updates.
CDC director Rochelle Walensky will be in charge of giving the final green light.
The new versions of the vaccines could potentially be available in the United States as early as next week.
"Receiving a booster that specifically targets the Omicron BA.4/.5 variant, currently the most prevalent strain of SARS-CoV-2, is an important public health measure that people can take to help protect themselves, especially as we head into a season filled with indoor gatherings," Moderna chief executive Stephane Bancel said in a statement.
The vaccines currently in circulation target the initial strain of the virus that first appeared in Wuhan, China. But they have gradually proven to be less effective against the variants that have appeared over time, due to rapid evolution of the virus.
In contrast to the Alpha and Delta variants, which eventually waned, Omicron and its subvariants have come to dominate infections worldwide in 2022.
Pfizer and Moderna have also filed for approval of their updated vaccines with the European Medicines Agency.
J.Bergmann--BTB
